Enteral Feeding Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

The Enteral Feeding Devices Market is Segmented by Product Type (Enteral Feeding Pumps, Enteral Feeding Tubes, and Other Product Types), Age Group (Adults and Pediatrics), End User (Hospitals, Ambulatory Care Services, and Other End Users), Application (Oncology, Neurology, Critical Care, Diabetes, Gastroenterology, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Enteral Feeding Devices Industry Overview

Enteral Feeding Devices Market Summary
Study Period: 2018 - 2028
Fastest Growing Market: Asia-Pacific
Largest Market: North America
CAGR: 6.5 %

Major Players

Enteral Feeding Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Enteral Feeding Devices Market Analysis

The enteral feeding devices market was valued at USD 3,735.79 million in 2021 and is expected to reach USD 5,451.06 million by 2027, registering a CAGR of 6.50% over the forecast period (2022-2027).

The COVID-19 pandemic significantly impacted the enteral feeding devices market globally. According to a research article titled "The Effects of Enteral Nutrition in Critically Ill Patients with COVID-19: A Systematic Review and Meta-Analysis" published in March 2022, due to the disturbance of the normal intestinal mucosa, patients with COVID-19 who are extremely unwell may have reduced nutrient absorption. They frequently have a considerable increase in their needs for protein and calories, as well as high levels of inflammation, stress, and catabolism. To prevent malnutrition in these patients, immediate enteral nutrition support and the administration of adequate nutrients are crucial. Moreover, according to guidelines by the European Society for Clinical Nutrition and Metabolism (ESPEN) on nutrition in the ICU, gastric enteral nutrition is advised for severe COVID-19 patients and should be preferably performed using a pump with a flow regulator within 48 hours of admission to the ICU. Hence, the COVID-19 pandemic increased the need for enteral feeding devices, especially for those in intensive care units, thereby positively impacting the market growth over the pandemic phase.

Moreover, the factors responsible for the market’s growth include the rising burden of chronic diseases, the increasing number of premature deaths, and the growing demand for enteral feeding in-home care settings.

The rising burden of chronic diseases is a major factor driving the market’s growth. For instance, as per the data published by the American Cancer Society, in 2022, nearly 26,380 new cases of stomach cancer and approximately 11,090 deaths from stomach cancer are estimated to occur in the year 2022. The organization further stated that gastric cancer accounts for about 1.5% of all new cancers diagnosed in the United States every year. Furthermore, as per a 2022 update by the International Foundation for Gastrointestinal Disorders (IFFGD), 10 to 15% of the population is affected by irritable bowel syndrome worldwide. Likewise, according to research conducted by Crohn's & Colitis UK in 2022, 1 in every 123 persons in the United Kingdom has ulcerative colitis or Crohn's disease. In the country, this equates to a total of close to 500,000 individuals who have IBD. Since these diseases are frequently associated with the progressive development of malnutrition, these statistics indicate that the demand for enteral feeding devices is anticipated to increase over the coming years. Thus, the high burden of chronic diseases is leading to an increased demand for enteral feeding devices, thereby contributing to market growth.

However, complications associated with enteral feeding tubes and healthcare reimbursement issues are the major factors restraining the market’s growth.

Enteral Feeding Devices Industry Segments

As per the scope of the report, enteral feeding refers to the delivery of a nutritionally complete feed containing protein, carbohydrates, fat, water, minerals, and vitamins directly into the stomach, duodenum, or jejunum through devices such as tubes and pumps. It is used for people who have a functional gastrointestinal tract but are unable to consume foods orally to meet their nutrient requirements. The enteral feeding devices market is segmented by product type (enteral feeding pumps, enteral feeding tubes, and other product types), age group (adults and pediatrics), end user (hospitals, ambulatory care services, and other end users), application (oncology, neurology, critical care, diabetes, gastroenterology, and other applications), and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Product Type
Enteral Feeding Pumps
Enteral Feeding Tubes
Other Product Types
By Age Group
Adults
Pediatrics
By End User
Hospitals
Ambulatory Care Services
Other End Users
By Application
Oncology
Neurology
Critical Care
Diabetes
Gastroenterology
Other Applications
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Enteral Feeding Devices Market Trends

This section covers the major market trends shaping the Enteral Feeding Devices Market according to our research experts:

Diabetes Segment Is Expected to Witness Significant Growth During the Forecast Period

By application, the diabetes segment is expected to witness substantial growth during the forecast period. The major factors fueling the growth of the segment are the increasing burden of diabetes, the growing geriatric population, and the increasing implementation of strategic initiatives by market players.

For instance, incidences of diabetes have increased over the years globally and are expected to increase further. As per a 2021 update by the International Diabetes Federation (IDF), approximately 537 million adults (20-79 years) are living with diabetes. As per the same source, the total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. The source also reports that 1 in 4 adults with diabetes live in low- and middle-income countries, and almost 1 in 2 (240 million) adults living with diabetes are undiagnosed. Enteral nutrition plays an important role in reducing the risk of malnutrition in diabetic patients by providing the necessary macro-and micronutrients, such as energy, protein, vitamins, and minerals. Thus, the demand for enteral feeding devices is likely to increase among the diabetic patient population in the near future.

Several market players are also engaged in implementing strategic initiatives, which are contributing to segment's growth. For instance, in July 2021, Medtronic received approval from the United States Food and Drug Administration (FDA) for its extended-wear infusion set, designed to last more than twice as long as existing infusion sets that connect traditional tubed pumps to the body for insulin delivery.

Thus, the aforementioned factors are anticipated to boost the segment’s growth throughout the analysis period.

Enteral Feeding Devices Market : Incidence of Diabetes (in million), Global, 2019-2045

North America Expected to Dominate the Enteral Feeding Devices Market over the Forecast Period

The North American region, particularly the United States, has a developed and well-structured health care system. The region is a hub for research and development activities and encourages key players to establish their headquarters in the region through its policies and investment support.

An increase in the burden of chronic diseases, the geriatric population, and surgical procedures in the region are expected to drive the demand for enteral feeding devices to support the nutritional requirements of individuals who cannot ingest and digest food. For instance, as per statistics by the International Diabetes Federation (IDF) Diabetes Atlas, 10th Edition, in 2021, the number of people identified with diabetes in thousands was 32,215.3 in the United States, and the number is estimated to reach 36,289.9 by 2045. Patients with diabetes are likely to have a threefold higher risk of being hospitalized. Many of the consequences of improperly managed diabetes, such as strokes, can necessitate enteral feeding.

Likewise, as per the data published by the Canadian Cancer Society, in 2022, around 4,100 Canadians will be diagnosed with stomach cancer and 2,000 Canadians will die from the disease. Furthermore, the organization stated that approximately 2,600 men and about 1,450 women will be diagnosed with gastric cancer in the year 2022. Thus, such statistics indicate that the demand for enteral feeding devices for nutrition management within the country will increase over the coming years, ultimately boosting the market growth.

Moreover, market players are engaged in various strategies that are contributing to market growth. For instance, in May 2021, QMD reported the addition of Nasogastric Tubes to its Degania Enteral Feeding Product Portfolio. Nasogastric tubes are manufactured from premium materials and designed to comply with ENFit connection standards for improved patient safety. Likewise, in September 2021, Vonco Products’ EnteraLoc Flow direct-connect enteral nutritional delivery system received 510 (K) clearance from the United States Food and Drug Administration (USFDA). The system, which features a pouch with a leak-proof seal, Vonco’s direct-connect ENFit device, and a tube for food delivery, can deliver nutrition in either a hospital or home care setting and can be tailored to meet most dietary requirements.

Thus, due to the abovementioned developments, the market is expected to witness significant growth over the forecast period.

Enteral Feeding Devices Market : Growth Rate by Region

Enteral Feeding Devices Market Competitor Analysis

The enteral feeding devices market is highly competitive. In terms of market share, several companies, such as B. Braun Melsungen AG, Boston Scientific Corporation, Conmed Corporation, Cardinal Health, and Becton Dickinson and Company, among others, hold the highest market shares. The key players are evolving through various strategic alliances, such as acquisitions, collaborations, and new product launches, to expand the global product portfolio and secure their positions in the global market.

Enteral Feeding Devices Market Top Players

  1. B. Braun Melsungen AG

  2. Boston Scientific Corporation

  3. Conmed Corporation

  4. Cardinal Health, Inc.

  5. Becton, Dickinson and Company

*Disclaimer: Major Players sorted in no particular order

Enteral Feeding Devices Market Concentration

Enteral Feeding Devices Market Recent Developments

In April 2022, Fresenius Kabi launched a new enteral nutrition product app. The Enteral Nutrition Product App makes it easier for you to access detailed product information and includes a quick comparison tool to compare nutritional values against reference nutrient intakes.

In September 2021, Vonco Products LLC announced that the patented EnteraLoc Flow direct-connect enteral nutritional delivery system was granted 510(k) clearance by the U.S. Food and Drug Administration (FDA).

Enteral Feeding Devices Market Report - Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Burden of Chronic Diseases

      2. 4.2.2 Increasing Number of Premature Births

      3. 4.2.3 Growing Demand for Enteral Feeding in Home Care Settings

    3. 4.3 Market Restraints

      1. 4.3.1 Complications Associated with Enteral Feeding Tubes

      2. 4.3.2 Healthcare Reimbursement Issues

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value- USD million)

    1. 5.1 By Product Type

      1. 5.1.1 Enteral Feeding Pumps

      2. 5.1.2 Enteral Feeding Tubes

      3. 5.1.3 Other Product Types

    2. 5.2 By Age Group

      1. 5.2.1 Adults

      2. 5.2.2 Pediatrics

    3. 5.3 By End User

      1. 5.3.1 Hospitals

      2. 5.3.2 Ambulatory Care Services

      3. 5.3.3 Other End Users

    4. 5.4 By Application

      1. 5.4.1 Oncology

      2. 5.4.2 Neurology

      3. 5.4.3 Critical Care

      4. 5.4.4 Diabetes

      5. 5.4.5 Gastroenterology

      6. 5.4.6 Other Applications

    5. 5.5 Geography

      1. 5.5.1 North America

        1. 5.5.1.1 United States

        2. 5.5.1.2 Canada

        3. 5.5.1.3 Mexico

      2. 5.5.2 Europe

        1. 5.5.2.1 Germany

        2. 5.5.2.2 United Kingdom

        3. 5.5.2.3 France

        4. 5.5.2.4 Italy

        5. 5.5.2.5 Spain

        6. 5.5.2.6 Rest of Europe

      3. 5.5.3 Asia-Pacific

        1. 5.5.3.1 China

        2. 5.5.3.2 Japan

        3. 5.5.3.3 India

        4. 5.5.3.4 Australia

        5. 5.5.3.5 South Korea

        6. 5.5.3.6 Rest of Asia-Pacific

      4. 5.5.4 Middle-East and Africa

        1. 5.5.4.1 GCC

        2. 5.5.4.2 South Africa

        3. 5.5.4.3 Rest of Middle-East and Africa

      5. 5.5.5 South America

        1. 5.5.5.1 Brazil

        2. 5.5.5.2 Argentina

        3. 5.5.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 B. Braun Melsungen AG

      3. 6.1.3 Boston Scientific Corporation

      4. 6.1.4 Conmed Corporation

      5. 6.1.5 Cook Medical Inc.

      6. 6.1.6 Fresenius SE & Co. KGaA

      7. 6.1.7 Halyard Health Inc.

      8. 6.1.8 Nestle SA

      9. 6.1.9 Avanos Medical Inc.

      10. 6.1.10 Cardinal Health Inc.

      11. 6.1.11 Becton Dickinson and Company

      12. 6.1.12 Vygon SA

      13. 6.1.13 Applied Medical Technology Inc.

      14. 6.1.14 Amsino International Inc.

      15. 6.1.15 Fidmi Medical

      16. 6.1.16 ALCOR Scientific Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers Business Overview, Financials, Products and Strategies, and Recent Developments.
You can also purchase parts of this report. Do you want to check out a section wise price list?

Enteral Feeding Devices Market Research FAQs

The Enteral Feeding Devices Market is studied from 2018 - 2028.

The Enteral Feeding Devices Market is growing at a CAGR of 6.5% over the next 5 years.

The Enteral Feeding Devices Market is valued at 3735 Million USD in 2018.

The Enteral Feeding Devices Market is valued at 5451 Million USD in 2028.

Asia-Pacific is growing at the highest CAGR over 2018 - 2028.

North America holds highest share in 2021.

B. Braun Melsungen AG, Boston Scientific Corporation, Conmed Corporation, Cardinal Health, Inc., Becton, Dickinson and Company are the major companies operating in Enteral Feeding Devices Market.

Enteral Feeding Devices Industry Reports

In-depth industry statistics and market share insights of the Enteral Feeding Devices sector for 2020, 2021, and 2022. The Enteral Feeding Devices research report provides a comprehensive outlook of the market size and an industry growth forecast for 2023 to 2028. Available to download is a free sample file of the Enteral Feeding Devices report PDF.

close-icon
80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!